Caribbean Cream Limited (JMSE:KREMI)
Jamaica · Delayed Price · Currency is JMD 2.100
0.00 (0.00%)
At close: Jul 31, 2025
Kronos Bio Income Statement
Financials in millions JMD. Fiscal year is March - February.
Millions JMD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2017 - 2021 |
| 3,038 | 2,995 | 2,643 | 2,506 | 2,085 | 1,870 | Upgrade | |
Revenue Growth (YoY) | 8.57% | 13.31% | 5.46% | 20.18% | 11.51% | 9.60% | Upgrade |
Cost of Revenue | 2,159 | 2,085 | 1,793 | 1,793 | 1,532 | 1,273 | Upgrade |
Gross Profit | 878.93 | 910.27 | 849.5 | 713.11 | 553.61 | 597.65 | Upgrade |
Selling, General & Admin | 778.5 | 779.15 | 711.34 | 599.89 | 525.46 | 451.54 | Upgrade |
Other Operating Expenses | -6.38 | -7.24 | -0.66 | -0.99 | - | - | Upgrade |
Operating Expenses | 772.51 | 772.3 | 712.58 | 598.86 | 525.49 | 449.74 | Upgrade |
Operating Income | 106.42 | 137.96 | 136.92 | 114.25 | 28.12 | 147.91 | Upgrade |
Interest Expense | -116.2 | -109.09 | -91.9 | -57.42 | -29.38 | -21.43 | Upgrade |
Interest & Investment Income | 0.76 | 0.76 | 0.51 | 0.44 | 0.84 | 1.33 | Upgrade |
Currency Exchange Gain (Loss) | -2.9 | -2.9 | 9.76 | -8.38 | -6.94 | -2.97 | Upgrade |
Other Non Operating Income (Expenses) | -8.14 | -8.14 | -7.08 | -7.05 | -6.32 | -6.34 | Upgrade |
EBT Excluding Unusual Items | -20.06 | 18.58 | 48.21 | 41.84 | -13.69 | 118.5 | Upgrade |
Pretax Income | -20.06 | 18.58 | 48.21 | 41.84 | -13.69 | 118.5 | Upgrade |
Income Tax Expense | -8.87 | 0.79 | 11.47 | 14.73 | -4.54 | 17.82 | Upgrade |
Net Income | -11.19 | 17.79 | 36.74 | 27.11 | -9.15 | 100.68 | Upgrade |
Net Income to Common | -11.19 | 17.79 | 36.74 | 27.11 | -9.15 | 100.68 | Upgrade |
Net Income Growth | - | -51.57% | 35.52% | - | - | 84.50% | Upgrade |
Shares Outstanding (Basic) | 368 | 379 | 379 | 379 | 379 | 379 | Upgrade |
Shares Outstanding (Diluted) | 368 | 379 | 379 | 379 | 379 | 379 | Upgrade |
Shares Change (YoY) | -5.79% | - | - | - | 0.01% | - | Upgrade |
EPS (Basic) | -0.03 | 0.05 | 0.10 | 0.07 | -0.02 | 0.27 | Upgrade |
EPS (Diluted) | -0.03 | 0.05 | 0.10 | 0.07 | -0.02 | 0.27 | Upgrade |
EPS Growth | - | -51.57% | 35.52% | - | - | 84.50% | Upgrade |
Free Cash Flow | 15.03 | -44.3 | -70.34 | -426.81 | -355.64 | 41.43 | Upgrade |
Free Cash Flow Per Share | 0.04 | -0.12 | -0.19 | -1.13 | -0.94 | 0.11 | Upgrade |
Dividend Per Share | - | - | - | - | - | 0.069 | Upgrade |
Dividend Growth | - | - | - | - | - | 137.93% | Upgrade |
Gross Margin | 28.93% | 30.39% | 32.14% | 28.45% | 26.55% | 31.96% | Upgrade |
Operating Margin | 3.50% | 4.61% | 5.18% | 4.56% | 1.35% | 7.91% | Upgrade |
Profit Margin | -0.37% | 0.59% | 1.39% | 1.08% | -0.44% | 5.38% | Upgrade |
Free Cash Flow Margin | 0.50% | -1.48% | -2.66% | -17.03% | -17.05% | 2.21% | Upgrade |
EBITDA | 236.54 | 272.21 | 251.29 | 214.54 | 130.56 | 242.94 | Upgrade |
EBITDA Margin | 7.79% | 9.09% | 9.51% | 8.56% | 6.26% | 12.99% | Upgrade |
D&A For EBITDA | 130.12 | 134.25 | 114.36 | 100.29 | 102.45 | 95.03 | Upgrade |
EBIT | 106.42 | 137.96 | 136.92 | 114.25 | 28.12 | 147.91 | Upgrade |
EBIT Margin | 3.50% | 4.61% | 5.18% | 4.56% | 1.35% | 7.91% | Upgrade |
Effective Tax Rate | - | 4.27% | 23.79% | 35.20% | - | 15.04% | Upgrade |
Advertising Expenses | - | - | - | - | - | 16.77 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.